Second Opinion: Laetrile at Sloan-Kettering Explores the Controversial Cancer Treatment
Whistle-blower Ralph Moss.
Extracted from apricots, peaches, and almonds, Laetrile is one of the most controversial cancer treatments to approach the mainstream. The American Cancer Society's entry on it, which reads as ambivalent to suspicious, concludes, "Relying on this type of treatment alone, and avoiding or delaying conventional medical care for cancer, may have serious health consequences."
In Eric Merola's Second Opinion: Laetrile at Sloan-Kettering, the question of the drug's efficacy takes a backseat to the story of whistle-blower Ralph Moss, a science writer at Memorial Sloan-Kettering Cancer Center, who exposed the organization's attempt to squash promising research on the drug in the mid-1970s.
Like many docs with activist undertones, Second Opinion tells a potentially interesting story in a bland way — a fixed camera on its main subject, who recounts the story detail by detail. (There are some info graphics and archival footage thrown in for good measure, of course.)
Moss frames the early stages of the War on Cancer in the context of the powerlessness felt by Americans in the midst of that other war going on in the late '60s and early '70s, a fascinating thread that, like too many others in the film, is unraveled too quickly.
Get the Film & TV Newsletter
Stay up to date on the best new movies with our critics' latest reviews, interviews and trailers for the films coming to a theater near you each week.
More Film News
- Scott Adkins Plays a Badass Actually Named ‘Colt McReady’ In the Effective ‘Close Range’
- Meet the Pole Who Tried to Warn the World About the Holocaust in ‘Karski & the Lords...
- Jane Fonda Faced Down the Seventies and a Killer in Pakula’s Masterful ‘Klute’
- He’ll Get Your Head Shaking: Surveying the Start of Chung Mong-hong’s (Likely) Great...